KHI April Mixer: Aligning on a Pathway for Novel Immunosuppression Drugs for Transplantation
Join the Kidney Health Initiative (KHI) for an informal virtual discussion on opportunities to evaluate clinical trial endpoints for transplant immunosuppression drugs. KHI is planning a pre-competitive and collaborative project to catalyze the development of novel immunosuppression drugs, given the limited choices available for transplant recipients. KHI seeks feedback to ensure that a collaborative solution […]